Company news
ENDRA Life Sciences Inc. news in 2021
ENDRA Life Sciences Inc.'s news releases, calls and decks from 2021, newest first.
ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
December 12, 2021
ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
November 28, 2021
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents
November 15, 2021
ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
November 14, 2021
ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021
November 7, 2021
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property Protection with Issuance of 21st U.S. Patent
October 12, 2021
ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
August 11, 2021
ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021
August 1, 2021
ENDRA Life Sciences Announces Participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021
July 19, 2021
ENDRA Life Sciences Strengthens TAEUS(R) System Intellectual Property Protection with the Issuance of Three U.S. Patents
July 6, 2021
ENDRA Life Sciences Appoints Irina Pestrikova as Senior Director of Finance, Announces Departure of CFO David Wells
June 14, 2021
ENDRA Life Sciences Set to Join the Russell Microcap(R) Index
June 8, 2021
ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
May 16, 2021
ENDRA Life Sciences to Report First Quarter 2021 Financial Results on May 17, 2021
May 5, 2021
ENDRA Life Sciences Further Strengthens TAEUS(R) System's Intellectual Property Protection with Issuance of Two U.S. Patents
May 3, 2021
ENDRA Life Sciences Reports 2020 Fourth Quarter and Full Year Financial Results, Provides Business Update
March 24, 2021
ENDRA Life Sciences and Hepion Pharmaceuticals Partner to Drive Efficiencies in NASH Clinical Trials
March 17, 2021
ENDRA Life Sciences to Report Fourth Quarter 2020 Financial Results on March 25, 2021
March 16, 2021
ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland
February 16, 2021
ENDRA Life Sciences Further Strengthens TAEUS(R) System Intellectual Property Protection with Issuance of 14th U.S. Patent
January 25, 2021
ENDRA Life Sciences Granted 13th U.S. Patent for its TAEUS(R) Platform Technology
January 12, 2021
Calls in 2021
Decks in 2021
- Investor Presentation (March 2021)
Investor deck · 19 slides · Mar 5, 2021
- Investor Presentation (January 2021)
Investor deck · 18 slides · Jan 11, 2021